Abstract

We present a rare case of a newborn with H-type tracheoesophageal fistula (TEF) who developed pyloric stenosis postoperatively, 10 days after he was started on erythromycin to promote gastric emptying. We report this case to describe the relationship between H-type TEF repair, erythromycin therapy, and the development of infantile hypertrophic pyloric stenosis.

Highlights

  • We present a rare case of a newborn with H-type tracheoesophageal fistula (TEF) who developed pyloric stenosis postoperatively, 10 days after he was started on erythromycin to promote gastric emptying

  • The prevalence of Esophageal atresia (EA)/TEF has remained stable over time, at approximately 2.5/10,000 births [1]

  • While EA/TEF is commonly associated with other malformations over 50% of the time, the incidence of infantile hypertrophic pyloric stenosis (IHPS) in patients with EA/TEF is not well established

Read more

Summary

Introduction

We present a rare case of a newborn with H-type tracheoesophageal fistula (TEF) who developed pyloric stenosis postoperatively, 10 days after he was started on erythromycin to promote gastric emptying. A barium swallow was obtained on the 2nd day of life, demonstrating severe esophageal stenosis with near atresia, a large proximal pouch, and an associated tracheoesophageal fistula (TEF) at the level of the atresia. The patient was fed through a Replogle tube until undergoing operative repair at 10 days of age.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call